Abstract：OBJECTIVE: To study the role of urotensionII in serum and bronchoalveolar lavage fluid (BALF) in the process of airway remodelling in asthmatic rats. METHODS: Thirty-two male Sprague-Dawley (SD) rats were randomly divided into normal control and 2-week, 4-week and 8-week asthmatic groups (OVA inhalation of 2, 4 and 8 weeks respectively). Rats were sensitized and challenged by OVA to establish a model of asthma. The bronchial wall thickness and the airway smooth muscle thickness were measured by image analysis system. The urotension-II contents in serum and BALF were determined using ELISA. RESULTS: The bronchial wall thickness and the airway smooth muscle thickness in the three asthmatic groups significantly increased compared with those in the normal control group (P<0.01). The urotension-II contents in serum and BALF in the three asthmatic groups also increased significantly compared with those in the normal control group (P<0.01). The urotension-II contents in serum and BALF in the 8-week asthmatic group were the highest, followed by the 4-week and the 2-week asthmatic groups (P<0.01). BALF urotension-II contents were positively correlated with the bronchial wall thickness and the airway smooth muscle thickness as well as serum U-II contents in the four groups. CONCLUSIONS: The urotension-II contents in serum and BALF in the process of airway remodeling increase in asthmatic rats. The changes in serum and BALF urotension-II contents may be associated with airway remodeling in asthmatic rats.［Chin J Contemp Pediatr, 2010, 12 (4):287-289］
LIANG Ya-Feng,ZHANG Wei-Xi,LI Chang-Chong et al. Changes in urotensin-II expression in airway remodelling in asthmatic rats[J]. CJCP, 2010, 12(04): 287-289.
［1］Shenouda A, Douglas SA, Ohlstein EH, Giaid A. Localization of urotensin-II immunoreactivity in normal human kidneys and renal carcinoma ［J］. J Histochem Cytochem, 2002, 50(7): 885-889.
［2］Chen YH, Zhao MW, Yao WZ, Pang YZ, Tang CS. The signal transduction pathway in the proliferation of airway smooth muscle cells induced by urotensin II［J］. Chin Med J, 2004, 117(1):37-41.
［5］Russell FD, Meyers D, Galbraith AJ, Bett N, Toth I, Kearns P, et al. Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure［J］. Am J Physiol Heart Circ Physiol, 2003, 285(4):H1576-1581.
